U-61,431F , a stable prostacyclin analogue , inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells .

Shirotani M ; Yui Y ; Hattori R ; Kawai C

Department of Internal Medicine , Faculty of Medicine , Kyoto University , Japan .

Prostaglandins 41 : 97-110 ( 1991)

Abstract
The effects of U-61,431F , ciprostene , a stable prostacyclin analogue , were examined on the proliferation of cultured quiescent bovine aortic endothelial cells ( EC ) and smooth muscle cells ( SMC ) . After stimulation with 5% fetal calf serum , U-61,431F suppressed both the DNA synthesis and proliferation of SMC dose-dependently at the concentration of 3-100 microM , but had no effect on either of them in EC at a concentration of up to 30 microM . The inhibitory effect on DNA synthesis was greater in SMC than in EC at 3-50 microM . When SMC were stimulated with platelet-derived growth factor ( PDGF ) for 2 hrs followed by a 22-hr incubation with insulin , U-61,431F ( 1-50 microM ) administered at the time of PDGF stimulation did not inhibit DNA synthesis . SMC initiated and terminated DNA synthesis at about 15-18 h and 24 h after stimulation with serum , respectively . Inhibition of DNA synthesis in serum-stimulated SMC as a function of the addition time of U-61,431F reduced at 3-12 h after the stimulation . U-61,431F raised the cyclic AMP ( cAMP ) content in SMC . Moreover , a phosphodiesterase inhibitor , -isobutyl-1-methylxanthine , and a more specific cAMP phosphodiesterase inhibitor , Ro 20-1724 , augmented the inhibition of DNA synthesis in SMC concomitant with further elevation of cAMP level . These results suggest that U-61,431F inhibits DNA synthesis of SMC acting in the progression stage rather than in the competence stage , with little antiproliferative effect on EC . cAMP may play an important role in its antiproliferative action in SMC .